top of page
it's where dermatology lives



Long-term impacts of SJS, TEN investigated
Early stage TEN. Photo by Jay2Base via Wikimedia Commons Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) may be rare, but for many patients the crisis does not end at hospital discharge. A new qualitative study published in JAMA Dermatology describes years of persistent physical, psychological, and social fallout—and a striking absence of structured post-discharge care. Investigators at Vanderbilt University Medical Center’s Center for Drug Safety and Imm
Allan Ryan
19 hours ago2 min read


Dr. Neil Shear speaks on SJS in first episode of new podcast
Dr. Neil Shear is launching a new podcast, Shear Listening Pleasure (SLP). In this program, the former Head of Dermatology at Sunnybrook...
John Evans
Jul 13, 20211 min read
Featured Posts




bottom of page

